Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Storb

Showing results (131-140 of 315) with videos related to

Pageof 32
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2009
What is the role for donor natural killer cells after nonmyeloablative conditioning?Frédéric Baron, Effie W Petersdorf, Ted Gooley, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 12, 2007
Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppressionZejing Wang, Christian S Kuhr, James M Allen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 4, 2014
Impact of donor age on outcome after allogeneic hematopoietic cell transplantationAndrew R Rezvani, Barry E Storer, Katherine A Guthrie, et al.
Transplantation and Cellular Therapy|September 6, 2020
Corrigendum to 'Anti-ICOS Monoclonal Antibody Treatment of Canine Chronic GVHD' [Biology of Blood and Marrow Transplantation 24/1 (2018) 50-54]Scott S Graves, Maura H Parker, Diane Stone, et al.
British Journal of Haematology|February 14, 2002
Type of post-grafting immunosuppression after non-myeloablative blood cell transplantation may influence risk of delayed haemolysis due to minor ABO incompatibilityMarco Mielcarek, J Maciej Zaucha, Brenda Sandmaier, et al.
Cytotherapy|August 18, 2011
Immunomodulatory effects induced by cytotoxic T lymphocyte antigen 4 immunoglobulin with donor peripheral blood mononuclear cell infusion in canine major histocompatibility complex-haplo-identical non-myeloablative hematopoietic cell transplantationYun Chen, Takahiro Fukuda, Monica S Thakar, et al.
Human Gene Therapy|December 21, 2006
Immunity to adeno-associated virus-mediated gene transfer in a random-bred canine model of Duchenne muscular dystrophyZejing Wang, James M Allen, Stanley R Riddell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 19, 2013
Allogeneic hematopoietic cell transplantation following minimal intensity conditioning: predicting acute graft-versus-host disease and graft-versus-tumor effectsRainer Storb, Boglarka Gyurkocza, Barry E Storer, et al.
Research Square|November 28, 2024
Relationship Between Age, Conditioning Intensity, and Outcome After Allografting in Adults Age ≥60 Years with AMLPhuong Vo, Brenda Sandmaier, Megan Othus, et al.
Transplantation|February 18, 2003
Adoptive immunotherapy against kidney targets in dog-leukocyte antigen-identical mixed hematopoietic canine chimerasChristian Junghanss, Alessandra Takatu, Marie-Terese Little, et al.
Pageof 32

Showing results (131-140 of 315) with videos related to

Sort By:
Pageof 32
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2009
What is the role for donor natural killer cells after nonmyeloablative conditioning?Frédéric Baron, Effie W Petersdorf, Ted Gooley, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 12, 2007
Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppressionZejing Wang, Christian S Kuhr, James M Allen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 4, 2014
Impact of donor age on outcome after allogeneic hematopoietic cell transplantationAndrew R Rezvani, Barry E Storer, Katherine A Guthrie, et al.
Transplantation and Cellular Therapy|September 6, 2020
Corrigendum to 'Anti-ICOS Monoclonal Antibody Treatment of Canine Chronic GVHD' [Biology of Blood and Marrow Transplantation 24/1 (2018) 50-54]Scott S Graves, Maura H Parker, Diane Stone, et al.
British Journal of Haematology|February 14, 2002
Type of post-grafting immunosuppression after non-myeloablative blood cell transplantation may influence risk of delayed haemolysis due to minor ABO incompatibilityMarco Mielcarek, J Maciej Zaucha, Brenda Sandmaier, et al.
Cytotherapy|August 18, 2011
Immunomodulatory effects induced by cytotoxic T lymphocyte antigen 4 immunoglobulin with donor peripheral blood mononuclear cell infusion in canine major histocompatibility complex-haplo-identical non-myeloablative hematopoietic cell transplantationYun Chen, Takahiro Fukuda, Monica S Thakar, et al.
Human Gene Therapy|December 21, 2006
Immunity to adeno-associated virus-mediated gene transfer in a random-bred canine model of Duchenne muscular dystrophyZejing Wang, James M Allen, Stanley R Riddell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 19, 2013
Allogeneic hematopoietic cell transplantation following minimal intensity conditioning: predicting acute graft-versus-host disease and graft-versus-tumor effectsRainer Storb, Boglarka Gyurkocza, Barry E Storer, et al.
Research Square|November 28, 2024
Relationship Between Age, Conditioning Intensity, and Outcome After Allografting in Adults Age ≥60 Years with AMLPhuong Vo, Brenda Sandmaier, Megan Othus, et al.
Transplantation|February 18, 2003
Adoptive immunotherapy against kidney targets in dog-leukocyte antigen-identical mixed hematopoietic canine chimerasChristian Junghanss, Alessandra Takatu, Marie-Terese Little, et al.
Pageof 32